Evaluating the Effect of Axillary Lymph Node Involvement and Dissection in the Development of Post-Mastectomy Lymphedema Axillary Dissection and Post-mastectomy Lymphedema
Main Article Content
Keywords
breast cancer, mastectomy, lymphedema
Abstract
Background:
Lymphedema of the upper extremity is a serious consequence of breast cancer surgery. Postmastectomy lymphedema of the upper limb is usually related to many risk factors, like axillary surgery, radiotherapy, venous obstruction, obesity, and infection. In the current study, the objective was to identify the relationship between the extent of lymph node involvement and axillary dissection on the development of lymphedema.
Patients and methods:
One hundred and seventy patients managed by modified radical mastectomy with axillary dissection for mammary invasive adenocarcinoma between January 2009 and December 2016 in Al Fayhaa Teaching Hospital. The patients were divided into three groups according to the number of lymph nodes involved, by pathology. The patients had been followed up for at least two years and assessed by standard lymphedema assessment, then categorized into three groups, according to the severity of lymphedema.
Results:
After the analysis of patient parameters, the highest age group was 36-45 years. More than 60% of the patients had 4 9 lymph nodes involved. Forty-one patients from 170 developed lymphedema postoperatively. Forty patients had seroma and twenty-one patients had wound infection postoperatively.
Conclusion:
Post-mastectomy lymphedema is a sequela of disease process related to the extent of lymph node involvement and resection rather than an operative fault.
References
1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Williams NS, Bulstrode CJ, Connell PR, Bailey and Love’s Short Practice of Surgery, 25th ed., Hodder Education, p. 1430, 2008.
3. Townsend CM, Beauchamp RD, Evers BM, Mattox KL, Sabiston Textbook of Surgery the Biological Basis of Modern Surgical Practice,17th ed., Elsevier, 2316, 2004.
4.Throckmorton AD, AskgardGiesmann J, Hoskin TL, Bjarnason H, Donohue JH, Boughey JC, et al. Sclerotherapy for the treatment of postmastectomy seroma. Am J Surg. 2008;196(4):541-4.
5. Clark B, Sitzia J, and Harlow W, Incidence and risk of arm edema following treatment for breast cancer: a three-year follow-up study, QJM, 2005; 98(5):343-348.
6. International Society of Lymphology, The diagnosis, and treatment of peripheral lymphedema. 2009 Consensus Document of the International Society of Lymphology, Lymphology, 2009;42(2):51-60.
7. Cemal Y, Pusic A, Mehrara BJ. Preventative measures for lymphedema: separating fact from fiction. Journal of the American College of Surgeons. 2011 Oct 1;213(4):543-51.
8. Lawenda BD, Mondry TE, and Johnstone PAS, Lymphedema: a primary on the identification and management of a chronic condition in oncologic treatment. CA Cancer Journal for Clinicians. 2009;59(1):8-24.
9. Knott EM, Tune JD, Stoll ST, Downey F. Increase lymphatic flow in the thoracic duct during manipulative intervention. J Am Osteopath Assoc. 2005;105:447-456.
10. Revis RR. Lymphedema. [emedicine.com Web site]. October 25, 2005. Available at: http://www.emedicine.com/med/topic2722.htm. Accessed January 19, 2006.
11. Loudon A, Barnett T, Piller N, Immink MA, Visentin D, Williams AD. The effect of yoga on a woman with secondary arm lymphedema from breast cancer treatment. BMC Complement Altern Med [online] 2014 Oct.
12. Johansson K, Holmstrom H, Nilsson I, Ingvar C, Albertsson M, Ekdahl C. Breast cancer patients experiences of lymphedema. Scan J Caring Sci. 2003;17:35-42.
13. Disipio S, Rye B. Newman, and Hayes, Incidence of unilateral arm lymphedema after breast cancer: a systematic review and meta-analysis. The Lancet Oncology. 2013;14(6):500-515.
14. McLaughlin SA. Chapter 40: Lymphedema, in Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the Breast, 5th edition. Lippincott Williams and Wilkins, 2014.
15. Markowski J, Wilcox JP, Helm PA. Lymphedema incidence after specific post-mastectomy therapy. Arch Phys Med Rehab. 1981;62:449-52.
16. Margaret LF. Lymphedema. In Berger AM, Portenoy RK, Weissman ED, editor. Principle and Practice of Supportive Oncology. New York: Lippincott-Raven;1998:275-89.
17. Paskett ED, Naughton MJ, McCoy TP, Case LD, and Abbott JM. The epidemiology of arm and hand swelling in the premenopausal breast cancer survivor. Cancer Epidemiology Biomarkers and Prevention. 2007;16(4):775-82.
18. Ozalsan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg. 2004;187:69-72.
19. DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphedema after breast cancer: a systemic review and meta-analysis. Lancet Oncol. 2013;14(6):500-15.
20. Akinci M, Cetin B, Aslan S, Kulacoglu H. Factors affecting seroma formation after mastectomy with full axillary dissection. Acta Chir Belg. 2009;109:481-83.
21. Porter KA, O’Connor S, Rimm E, Lopez M. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg. 1998;176:8-11. 10. 1016/S0002-9610(98)00093-2.
22. Petrek JA, Peters MM, Nori S et al. Axillary lymphadenectomy: a prospective randomized trial of 13 factors influencing drainage including early or delayed arm mobilization. Arch Surg. 1990;125:378-82.
23. Deo SVS, Ray S, Rath GK, et al. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian Journal of Cancer. 2004;41(1):8-12.
24. Meeske KA, Sullivan-Halley J, Smith AW, et al. Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Research and Treatment. 2009;113(2):383-91.
25. Goldberg JI, Riedel ER, Morrow M, and Van Zee KJ. Morbidity of sentinel node biopsy: relationship between number of excised lymph nodes and patient perceptions of lymphedema, Annals of Surgical Oncology. 2011;18(10):2866-72.
26. Foldi M, Foldi E, and Kubik SFE. Textbook of Lymphology for Physicians and Lymphedema Therapist. 1st ed. Munich, Germany: Urban and Ficher; 2003.
27. McLaughlin SA, Bagaria S, Gibson T, et al. Trends in risk reduction practices for the prevention of lymphedema in the first 12 months after breast cancer surgery. J Am Coll Surg. 2003;216(3):380-9.
28. De Gourny E, Guyomard A, Coutant C, et al. Impact of sentinel node biopsy on long-term quality of life in breast cancer patients. Be J Cancer. 2013;109(11):2783-91.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.